During the last session, Molecular Data Inc. (NASDAQ:MKD)’s traded shares were 1,240,028, with the beta value of the company hitting 0. At the end of the trading day, the stock’s price was $1.04, reflecting an intraday loss of -2.8% or -$0.03. The 52-week high for the MKD share is $3.89, that puts it down -274.04% from that peak though still a striking +25% gain since the share price plummeted to a 52-week low of $0.78. The company’s market capitalization is $138.71 Million, and the average intraday trading volume over the past 10 days was 2.17 Million shares, and the average trade volume was 7.94 Million shares over the past three months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Molecular Data Inc. (MKD) received a consensus recommendation of 0 from analysts. That translates to a mean rating of 0. MKD has a Sell rating from none of the analyst(s) out of 0 analysts who have looked at this stock. Neither of the analyst(s) recommend to Hold the stock while none of them suggest Overweight, and no one recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.06.

Molecular Data Inc. (NASDAQ:MKD): Trading Information

Molecular Data Inc. (MKD) registered a -2.8% downside in the last session and has traded in the red over the past 5 sessions. The stock spiked 11.79% in intraday trading to $1.179 this Thursday, Apr 01, hitting a weekly high. The stock’s 5-day price performance is -2.8%, and it has moved by -17.46% in 30 days. Despite these dips, the overall price performance for the year is 23.81%. The short interest in Molecular Data Inc. (NASDAQ:MKD) is 1.82 Million shares and it means that shorts have 0.23 day(s) to cover.

Molecular Data Inc. (MKD) projections and forecasts

An analysis of the company’s performance over the past 5 years shows that the company’s earnings fell an estimated 0%. While earnings are projected to return 0% in 2021, the next five years will return 0% per annum.

Molecular Data Inc. (NASDAQ:MKD)’s Biggest Investors

Molecular Data Inc. insiders own 0% of total outstanding shares while institutional holders control 23.1%, with the float percentage being 23.1%. TB Alternative Assets Ltd. is the largest shareholder of the company, while 7 institutions own stock in it. As of Dec 30, 2020, the company held over 17.65 Million shares (or 15.85% of all shares), a total value of $14.82 Million in shares.

The next largest institutional holding, with 4.94 Million shares, is of Shen, Neil, Nanpeng’s that is approximately 4.43% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $4.15 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

LEAVE A REPLY

Please enter your comment!
Please enter your name here